Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Liang

Showing results (1051-1060 of 1,136) with videos related to

Pageof 114
Sort By:
Blood Neoplasia|August 12, 2025
Real-world performance of the CALGB 10403 regimen in young adults in the United StatesBrandon DaSilva, Alicia Darwin, Amy Zhang, et al.
Science (New York, N.Y.)|February 2, 2008
Cancer proliferation gene discovery through functional genomicsMichael R Schlabach, Ji Luo, Nicole L Solimini, et al.
Cancer Research|August 17, 2000
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumorsA D Laird, P Vajkoczy, L K Shawver, et al.
Cancer Immunology Research|January 20, 2019
PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8<sup>+</sup> T-cell FunctionSarah Whelan, Eran Ophir, Maya F Kotturi, et al.
IJTLD Open|May 14, 2025
Evaluating disability, comorbidities and risk factors after TB treatment: an 18-24 month follow-upY Sun, Y Lin, J E Golub, et al.
Oncogene|September 1, 1999
Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancerU S Khoo, H Ozcelik, A N Cheung, et al.
The Journal of Chemical Physics|October 26, 2010
Pressure-dependent electronic structures in multiferroic DyMnO(3): A combined lifetime-broadening-suppressed x-ray absorption spectroscopy and ab initio electronic structure studyJ M Chen, J M Lee, T L Chou, et al.
Blood|April 18, 2024
Human herpesvirus 6 reactivation and disease are infrequent in chimeric antigen receptor T-cell therapy recipientsEleftheria Kampouri, Elizabeth M Krantz, Hu Xie, et al.
Journal of the Neurological Sciences|July 31, 2021
Neurology trial registrations on ClinicalTrials.gov between 2007 and 2018: A cross-sectional analysis of characteristics, early discontinuation, and results reportingBrandon E Turner, Christopher J Magnani, Alexander Frolov, et al.
Blood Advances|January 17, 2025
Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALLJordan Gauthier, Emily C Liang, Jennifer J Huang, et al.
Pageof 114

Showing results (1051-1060 of 1,136) with videos related to

Sort By:
Pageof 114
Blood Neoplasia|August 12, 2025
Real-world performance of the CALGB 10403 regimen in young adults in the United StatesBrandon DaSilva, Alicia Darwin, Amy Zhang, et al.
Science (New York, N.Y.)|February 2, 2008
Cancer proliferation gene discovery through functional genomicsMichael R Schlabach, Ji Luo, Nicole L Solimini, et al.
Cancer Research|August 17, 2000
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumorsA D Laird, P Vajkoczy, L K Shawver, et al.
Cancer Immunology Research|January 20, 2019
PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8<sup>+</sup> T-cell FunctionSarah Whelan, Eran Ophir, Maya F Kotturi, et al.
IJTLD Open|May 14, 2025
Evaluating disability, comorbidities and risk factors after TB treatment: an 18-24 month follow-upY Sun, Y Lin, J E Golub, et al.
Oncogene|September 1, 1999
Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancerU S Khoo, H Ozcelik, A N Cheung, et al.
The Journal of Chemical Physics|October 26, 2010
Pressure-dependent electronic structures in multiferroic DyMnO(3): A combined lifetime-broadening-suppressed x-ray absorption spectroscopy and ab initio electronic structure studyJ M Chen, J M Lee, T L Chou, et al.
Blood|April 18, 2024
Human herpesvirus 6 reactivation and disease are infrequent in chimeric antigen receptor T-cell therapy recipientsEleftheria Kampouri, Elizabeth M Krantz, Hu Xie, et al.
Journal of the Neurological Sciences|July 31, 2021
Neurology trial registrations on ClinicalTrials.gov between 2007 and 2018: A cross-sectional analysis of characteristics, early discontinuation, and results reportingBrandon E Turner, Christopher J Magnani, Alexander Frolov, et al.
Blood Advances|January 17, 2025
Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALLJordan Gauthier, Emily C Liang, Jennifer J Huang, et al.
Pageof 114